Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2-Reference-Cited by-同舟云学术

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Published:2004-02 Issue:6974 Volume:427 Page:537-541
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Rost Simone,Fregin Andreas,Ivaskevicius Vytautas,Conzelmann Ernst,Hörtnagel Konstanze,Pelz Hans-Joachim,Lappegard Knut,Seifried Erhard,Scharrer Inge,Tuddenham Edward G. D.,Müller Clemens R.,Strom Tim M.,Oldenburg Johannes

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature02214.pdf

Reference23 articles.

1. Suttie, J. W. The biochemical basis of warfarin therapy. Adv. Exp. Med. Biol. 214, 3–16 (1987)

2. Nelsestuen, G. L., Zytkovicz, T. H. & Howard, J. B. The mode of action of vitamin K. Identification of γ-carboxyglutamic acid as a component of prothrombin. J. Biol. Chem. 249, 6347–6350 (1974)

3. Stenflo, J., Fernlund, P., Egan, W. & Roepstorff, P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc. Natl Acad. Sci. USA 71, 2730–2733 (1974)

4. Fasco, M. J., Principe, L. M., Walsh, W. A. & Friedman, P. A. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes. Biochemistry 22, 5655–5660 (1983)

5. Cain, D., Hutson, S. M. & Wallin, R. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane. J. Biol. Chem. 272, 29068–29075 (1997)

Cited by 989 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Warfarin Dose Maintenance Associated with CYP2C9*2 (rs1799853) and CYP2C9*3 (rs1057910) Gene Polymorphism in North Coastal Andhra Pradesh;The Open Biochemistry Journal;2024-08-29

2. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

3. The Influence of Genetic Polymorphisms on Warfarin Dosage Requirements in Cardiac Valve Surgery Patients;Cukurova Anestezi ve Cerrahi Bilimler Dergisi;2024-06-30

4. Warfarin analogs target disulfide bond-forming enzymes and suggest a residue important for quinone and coumarin binding;Journal of Biological Chemistry;2024-06

5. Short-term treatment with cholestyramine increases long-acting anticoagulant rodenticide clearance from rabbits without affecting plasma vitamin K1 levels or blood coagulation;Toxicological Sciences;2024-04-11